Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”

Claudio U. Köser; Jan Heyckendorf; Sönke Andres; Ioana D. Olaru; Thomas Schön; Erik Sturegård; Patrick Beckert; Viola Schleusener; Thomas A. Kohl; Doris Hillemann; Danesh Moradigaravand; Julian Parkhill; Sharon J. Peacock; Stefan Niemann; Christoph Lange; Matthias Merker

doi:10.1128/AAC.00616-18

Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”

Claudio U. Köser, Jan Heyckendorf, Sönke Andres, Ioana D. Olaru, Thomas Schön, Erik Sturegård, Patrick Beckert, Viola Schleusener, Thomas A. Kohl, Doris Hillemann, Danesh Moradigaravand, Julian Parkhill, Sharon J. Peacock, Stefan Niemann, Christoph Lange^*, Matthias Merker

^*Corresponding author for this work

Clinic of Internal Medicine III - Pulmonology

Original language	English
Article number	e00616-18
Journal	Antimicrobial Agents and Chemotherapy
Volume	62
Issue number	8
ISSN	0066-4804
DOIs	https://doi.org/10.1128/AAC.00616-18
Publication status	Published - 08.2018

Funding

This study was funded by the German Ministry of Education and Research (BMBF) for the German Center of Infection Research (DZIF) and the Health Innovation Challenge Fund (grants HICF-T5-342 and WT098600), a parallel-funding partnership between the UK Department of Health and the Wellcome Trust.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Access to Document

10.1128/AAC.00616-18

Cite this

Köser, C. U., Heyckendorf, J., Andres, S., Olaru, I. D., Schön, T., Sturegård, E., Beckert, P., Schleusener, V., Kohl, T. A., Hillemann, D., Moradigaravand, D., Parkhill, J., Peacock, S. J., Niemann, S., Lange, C., & Merker, M. (2018). Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”. Antimicrobial Agents and Chemotherapy, 62(8), Article e00616-18. https://doi.org/10.1128/AAC.00616-18

@article{6070176a35c441a8a0525e2a7e500492,

title = "Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”",

author = "K{\"o}ser, \{Claudio U.\} and Jan Heyckendorf and S{\"o}nke Andres and Olaru, \{Ioana D.\} and Thomas Sch{\"o}n and Erik Stureg{\aa}rd and Patrick Beckert and Viola Schleusener and Kohl, \{Thomas A.\} and Doris Hillemann and Danesh Moradigaravand and Julian Parkhill and Peacock, \{Sharon J.\} and Stefan Niemann and Christoph Lange and Matthias Merker",

note = "Funding Information: This study was funded by the German Ministry of Education and Research (BMBF) for the German Center of Infection Research (DZIF) and the Health Innovation Challenge Fund (grants HICF-T5-342 and WT098600), a parallel-funding partnership between the UK Department of Health and the Wellcome Trust. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",

year = "2018",

month = aug,

doi = "10.1128/AAC.00616-18",

language = "English",

volume = "62",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "8",

}

Köser, CU, Heyckendorf, J, Andres, S, Olaru, ID, Schön, T, Sturegård, E, Beckert, P, Schleusener, V, Kohl, TA, Hillemann, D, Moradigaravand, D, Parkhill, J, Peacock, SJ, Niemann, S, Lange, C & Merker, M 2018, 'Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”', Antimicrobial Agents and Chemotherapy, vol. 62, no. 8, e00616-18. https://doi.org/10.1128/AAC.00616-18

TY - JOUR

T1 - Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”

AU - Köser, Claudio U.

AU - Heyckendorf, Jan

AU - Andres, Sönke

AU - Olaru, Ioana D.

AU - Schön, Thomas

AU - Sturegård, Erik

AU - Beckert, Patrick

AU - Schleusener, Viola

AU - Kohl, Thomas A.

AU - Hillemann, Doris

AU - Moradigaravand, Danesh

AU - Parkhill, Julian

AU - Peacock, Sharon J.

AU - Niemann, Stefan

AU - Lange, Christoph

AU - Merker, Matthias

N1 - Funding Information: This study was funded by the German Ministry of Education and Research (BMBF) for the German Center of Infection Research (DZIF) and the Health Innovation Challenge Fund (grants HICF-T5-342 and WT098600), a parallel-funding partnership between the UK Department of Health and the Wellcome Trust. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.

PY - 2018/8

Y1 - 2018/8

UR - https://www.scopus.com/pages/publications/85050778828

U2 - 10.1128/AAC.00616-18

DO - 10.1128/AAC.00616-18

M3 - Letters

C2 - 30054377

AN - SCOPUS:85050778828

SN - 0066-4804

VL - 62

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 8

M1 - e00616-18

ER -

Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”

Funding

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Cite this